Are the side effects of ribociclib serious? How to alleviate adverse reactions?

Ribociclib is a targeted drug that is a CDK4/6 inhibitor and is widely used to treat HR-positive, HER2-negative breast cancer. It inhibits the proliferation of cancer cells by inhibiting cyclin-dependent kinases 4 and 6 (CDK4/6), preventing tumor cells from dividing. In clinical application, ribociclib can significantly improve the therapeutic effect of breast cancer patients, especially when combined with endocrine therapy drugs. But like all drugs, the use of ribociclib may be accompanied by certain side effects, and patients need to be closely monitored and managed while receiving treatment.
Common side effects of ribociclib
The side effects of ribociclib include but are not limited to: bone marrow suppression, gastrointestinal reactions, liver function abnormalities, and QT interval prolongation. First, bone marrow suppression is one of the most common side effects of ribociclib, manifested by symptoms such as leukopenia, thrombocytopenia, and anemia. Such side effects often cause patients to experience uncomfortable symptoms such as susceptibility to infection, bleeding, or fatigue. Secondly, ribociclib may also cause gastrointestinal discomfort, including nausea, vomiting, loss of appetite, and diarrhea. These symptoms are usually mild to moderate, especially early in drug treatment.

In addition, ribociclib may affect liver function during use, leading to an increase in liver enzyme levels, and patients may suffer from symptoms of impaired liver function such as jaundice and loss of appetite. Therefore, regular monitoring of liver function is necessary during treatment. Finally, ribociclib may cause QT prolongation, an electrocardiogram abnormality that may increase the risk of serious cardiac arrhythmias. Patients should undergo electrocardiogram examinations during medication, especially those with other cardiovascular diseases.

Serious side effects and countermeasures
Although the side effects of ribociclib are usually controllable, in some cases more serious reactions may occur, such as severe leukopenia, liver function damage, and significant prolongation of the QT interval. When these serious side effects occur, treatment may need to be adjusted. For example, if a decrease in white blood cells or platelets is detected, the doctor may recommend suspending ribociclib until blood markers return to normal before restarting treatment. For severe hepatic dysfunction, the dose of ribociclib may need to be reduced or, if necessary, treatment withheld.
In the case of QT prolongation, doctors usually recommend that patients undergo electrocardiogram monitoring. If the QT interval is found to exceed clinically safe values, ribociclib may need to be suspended or discontinued. In addition, the use of ribociclib requires special caution in patients with heart disease, and other drugs or treatments may be needed to alleviate side effects.
Measures to alleviate the side effects of ribociclib
For most patients, the side effects of ribociclib are controllable, and timely and appropriate intervention can significantly reduce uncomfortable symptoms. Gastrointestinal reactions can be alleviated by adjusting eating habits, such as eating smaller meals more frequently and avoiding greasy and irritating foods. If nausea and vomiting occur, patients can use antiemetic drugs under the guidance of a doctor to relieve discomfort.
For leukopenia and thrombocytopenia caused by bone marrow suppression, patients should undergo regular blood tests and adjust the treatment plan based on the test results. In some cases, medications that stimulate the production of white blood cells, such as granulocyte stimulating factor (G-CSF), may be considered to reduce the risk of infection. In addition, strengthening the immune system and preventing infection are also important mitigation measures. Patients can avoid contact with sources of infection and maintain good personal hygiene.
As a targeted drug, ribociclib can effectively treat HR-positive, HER2-negative breast cancer and improve the survival of patients. However, like all anti-cancer drugs, it has certain side effects. Common side effects include bone marrow suppression, gastrointestinal discomfort, liver function impairment, and QT interval prolongation. When using ribociclib, patients need to undergo regular monitoring, especially blood routine, liver function and electrocardiogram tests, so that potential side effects can be detected early and corresponding measures can be taken.
Reference: https://us.kisqali.com/